查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598802

子宮肌瘤治療設備市場：依技術及治療方法分類－2025年至2030年全球預測

Uterine Fibroid Treatment Device Market by Technology (Ablation Techniques, Embolization Techniques, Laparoscopic Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年子宮肌瘤治療器械市值為5.6039億美元，預計到2024年將達到6.1832億美元，複合年成長率為10.43%，預計到2030年將達到11.2236億美元。

子宮肌瘤治療設備市場包括為診斷和治療子宮肌瘤（子宮內的非癌性生長）而開發的專用醫療設備。這些設備在取代子宮切除術等傳統手術方法的微創手術中發揮著至關重要的作用。對此類設備的需求是由於子宮肌瘤的盛行率不斷增加，尤其是育齡婦女，以及人們越來越偏好減少恢復時間和手術風險的微創手術。主要應用包括診斷和治療影像技術，例如超音波、射頻消融術和腹腔鏡設備，這些技術供應給醫院、門診手術中心和專科診所。

主要市場統計
基準年[2023] 56039萬美元
預測年份 [2024] 61832萬美元
預測年份 [2030] 112,236 萬美元
複合年成長率（%） 10.43%

市場成長受到多種因素的影響，例如醫療技術的進步導致更有效和侵入性更小的治療選擇、醫療保健支出的增加以及對疾病及其治療選擇的認知的提高。人口老化和非裔美國女性發病率上升等人口趨勢也進一步推動需求。最近的市場趨勢包括在診斷設備中使用人工智慧來提高準確性並開拓易於在新興市場使用的經濟高效的解決方案。為了利用這些優勢，公司必須投資新設備的研發，並與醫療保健提供者合作以改善治療途徑。

然而，市場面臨著設備成本高、報銷挑戰以及可能阻礙更廣泛採用的監管障礙等限制。一個關鍵的挑戰是患者缺乏認知並且不願意選擇這些新治療方法而不是傳統方法。創新領域包括開發易於使用的門診設備以及整合遠距遠端醫療解決方案以擴大患者覆蓋範圍。市場競爭激烈且充滿活力，新參與企業不斷推出顛覆性技術。相關人員應專注於持續創新、策略夥伴關係和教育宣傳活動，以克服這些障礙並在這個不斷變化的環境中保持成長。

市場動態：快速發展的子宮肌瘤治療設備市場的關鍵市場洞察

子宮肌瘤治療設備市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球子宮肌瘤數量增加
    • 對微創設備的偏好日益成長
    • 增加技術先進產品的使用
  • 市場限制因素
    • 新興經濟體缺乏必要的基礎設施
  • 市場機會
    • 政府和組織為提高子宮肌瘤診斷相關意識所做的積極努力
    • 引進及開發技術先進的產品
  • 市場挑戰
    • 居民子宮肌瘤診斷意識下降

波特的五力：駕馭子宮肌瘤治療設備市場的策略工具

波特五力是了解子宮肌瘤治療器械市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解子宮肌瘤治療設備市場的外部影響

外部宏觀環境因素在塑造子宮肌瘤治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解子宮肌瘤治療器械市場的競爭狀況

子宮肌瘤治療設備市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣子宮肌瘤治療設備市場供應商的績效評估

FPNV 定位矩陣是評估子宮肌瘤治療設備市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃子宮肌瘤治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對子宮肌瘤治療設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 子宮肌瘤的發生率在全球範圍內不斷增加
      • 人們對微創設備的興趣日益濃厚
      • 增加技術先進產品的使用
    • 抑制因素
      • 新興經濟體缺乏必要的基礎設施
    • 機會
      • 政府和組織為提高對子宮肌瘤診斷的認知而採取的有利舉措
      • 引進及開發技術先進的產品
    • 任務
      • 大眾對設備的認知度下降
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章子宮肌瘤治療設備市場：依技術分類

  • 消融技術
    • 冷凍療法
    • 水熱消融
    • 微波消融
    • 超音波消融
      • 高強度聚焦超音波
      • MRI導引聚焦超音波
  • 栓塞術
  • 腹腔鏡技術
    • 腹腔鏡子宮肌瘤切除術
    • 肌溶解症
  • 手術技術
    • 子宮切除術
    • 子宮肌瘤切除術

第7章子宮肌瘤治療設備市場：依治療方法分類

  • 侵入性治療
  • 微創治療
  • 非侵入性治療

第8章北美和南美子宮肌瘤治療器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太子宮肌瘤治療器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲子宮肌瘤治療器械市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advanced Surgical Concepts
  • Boston Scientific Corporation
  • Conmed Corporation
  • Coopersurgical Inc.
  • Gynesonics, Inc.
  • Hologic, Inc.
  • Insightec Ltd.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Pentax Medical
  • Smith & Nephew PLC
  • Stryker Corporation
Product Code: MRR-0360AB17E12E

The Uterine Fibroid Treatment Device Market was valued at USD 560.39 million in 2023, expected to reach USD 618.32 million in 2024, and is projected to grow at a CAGR of 10.43%, to USD 1,122.36 million by 2030.

The uterine fibroid treatment devices market encompasses specialized medical equipment developed for diagnosing and treating uterine fibroids-non-cancerous growths in the uterus. These devices play a pivotal role in minimally invasive procedures that offer alternatives to traditional surgical methods like hysterectomy. The necessity for such devices stems from the increasing prevalence of uterine fibroids, particularly among women of childbearing age, coupled with a rising preference for minimally invasive procedures that reduce recovery time and surgical risks. Primary applications include imaging and treatment technologies such as ultrasound, radiofrequency ablation, and laparoscopic devices, catering to hospitals, ambulatory surgical centers, and specialty clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 560.39 million
Estimated Year [2024] USD 618.32 million
Forecast Year [2030] USD 1,122.36 million
CAGR (%) 10.43%

Market growth is influenced by factors such as advancements in medical technology leading to more effective and less invasive treatment options, increasing healthcare expenditure, and a growing awareness of the condition and its treatment alternatives. Demographic trends, including an aging population and higher incidence rates among African American women, further drive demand. Recent opportunities within the market involve leveraging AI in diagnostic devices to enhance accuracy and developing cost-effective solutions to widen accessibility in emerging markets. To capitalize on these, companies should invest in R&D for novel devices and collaborate with healthcare providers to improve treatment pathways.

However, the market faces limitations such as high device costs, reimbursement challenges, and regulatory hurdles, which may hinder broader adoption. A significant challenge is the lack of awareness and hesitancy among patients to opt for these newer treatment methods over traditional approaches. Innovation areas include the development of user-friendly devices that can be utilized in outpatient settings and the integration of telemedicine solutions to expand patient reach. The market is competitive and dynamic, with new entrants constantly introducing disruptive technologies. Stakeholders should focus on continuous innovation, strategic partnerships, and educational campaigns to overcome these barriers and sustain growth in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing occurrence of uterine fibroid worldwide
    • Growing penchant for minimally invasive devices
    • Rising utilization of technologically advanced products
  • Market Restraints
    • Shortage of required infrastructure in developing economies
  • Market Opportunities
    • Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
    • Introduction and development of technologically advanced products
  • Market Challenges
    • Reduced awareness of the device among population

Porter's Five Forces: A Strategic Tool for Navigating the Uterine Fibroid Treatment Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Uterine Fibroid Treatment Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Uterine Fibroid Treatment Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Uterine Fibroid Treatment Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Uterine Fibroid Treatment Device Market

A detailed market share analysis in the Uterine Fibroid Treatment Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Uterine Fibroid Treatment Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Uterine Fibroid Treatment Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Uterine Fibroid Treatment Device Market

A strategic analysis of the Uterine Fibroid Treatment Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uterine Fibroid Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Advanced Surgical Concepts, Boston Scientific Corporation, Conmed Corporation, Coopersurgical Inc., Gynesonics, Inc., Hologic, Inc., Insightec Ltd., Karl Storz SE & Co. KG, Medtronic PLC, Merit Medical Systems, Inc., Minerva Surgical, Inc., Olympus Corporation, Pentax Medical, Smith & Nephew PLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Uterine Fibroid Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Ablation Techniques, Embolization Techniques, Laparoscopic Techniques, and Surgical Techniques. The Ablation Techniques is further studied across Cryoablation, Hydrothermal Ablation, Microwave Ablation, and Ultrasound Ablation. The Ultrasound Ablation is further studied across High Intensity Focused Ultrasound and MRI-Guided Focused Ultrasound. The Laparoscopic Techniques is further studied across Laparoscopic Myomectomy and Myolysis. The Surgical Techniques is further studied across Hysterectomy and Myomectomy.
  • Based on Mode of Treatment, market is studied across Invasive Treatment, Minimally Invasive Treatment, and Non-Invasive Treatment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing occurrence of uterine fibroid worldwide
      • 5.1.1.2. Growing penchant for minimally invasive devices
      • 5.1.1.3. Rising utilization of technologically advanced products
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of required infrastructure in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
      • 5.1.3.2. Introduction and development of technologically advanced products
    • 5.1.4. Challenges
      • 5.1.4.1. Reduced awareness of the device among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Uterine Fibroid Treatment Device Market, by Technology

  • 6.1. Introduction
  • 6.2. Ablation Techniques
    • 6.2.1. Cryoablation
    • 6.2.2. Hydrothermal Ablation
    • 6.2.3. Microwave Ablation
    • 6.2.4. Ultrasound Ablation
      • 6.2.4.1. High Intensity Focused Ultrasound
      • 6.2.4.2. MRI-Guided Focused Ultrasound
  • 6.3. Embolization Techniques
  • 6.4. Laparoscopic Techniques
    • 6.4.1. Laparoscopic Myomectomy
    • 6.4.2. Myolysis
  • 6.5. Surgical Techniques
    • 6.5.1. Hysterectomy
    • 6.5.2. Myomectomy

7. Uterine Fibroid Treatment Device Market, by Mode of Treatment

  • 7.1. Introduction
  • 7.2. Invasive Treatment
  • 7.3. Minimally Invasive Treatment
  • 7.4. Non-Invasive Treatment

8. Americas Uterine Fibroid Treatment Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Uterine Fibroid Treatment Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Surgical Concepts
  • 2. Boston Scientific Corporation
  • 3. Conmed Corporation
  • 4. Coopersurgical Inc.
  • 5. Gynesonics, Inc.
  • 6. Hologic, Inc.
  • 7. Insightec Ltd.
  • 8. Karl Storz SE & Co. KG
  • 9. Medtronic PLC
  • 10. Merit Medical Systems, Inc.
  • 11. Minerva Surgical, Inc.
  • 12. Olympus Corporation
  • 13. Pentax Medical
  • 14. Smith & Nephew PLC
  • 15. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UTERINE FIBROID TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UTERINE FIBROID TREATMENT DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYDROTHERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MRI-GUIDED FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY EMBOLIZATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MINIMALLY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY NON-INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 280. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023